Evaluation of the C3435T polymorphism in the MDR1 gene in patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

Evaluation of the C3435T polymorphism in the MDR1 gene in patients with hepatocellular carcinoma

Published:2012-11 Issue:6 Volume:11 Page:899-906
ISSN:1665-2681
Container-title:Annals of Hepatology
language:en
Short-container-title:Annals of Hepatology

Author:

Dido Baldissera Vanessa,Alves de Mattos Angelo,Perdomo Coral Gabriela,Branco de Araujo Fernanda,Augusto Marroni Cláudio,Bandeira de Mello Brandao Ajácio,Roberto Ott Fontes Paulo,Thadeu Schmidt Cerski Carlos,Atalibio Hartmann Antonio,Alexandre Kretzmann Filho Nélson

Publisher

Elsevier BV

Subject

Hepatology,General Medicine

Reference31 articles.

1. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis;El-Serag;Gastroenterology,2007

2. Sorafenib in liver cancer-Just the beginning;Roberts;N Engl J Med,2008

3. Design and endpoints of clinical trials in hepatocellular carcinoma;Llovet;J Natl Cancer Inst,2008

4. Management of hepatocellular carcinoma: An update;Bruix;Hepatology,2011

5. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of MDR1 Gene Polymorphisms in Human Male Infertility: A Meta-Analysis;American Journal of Men's Health;2023-03

2. The association of genetic polymorphisms with neuroconnectivity in breast cancer patients;Scientific Reports;2021-03-17

3. Human variability in influx and efflux transporters in relation to uncertainty factors for chemical risk assessment;Food and Chemical Toxicology;2020-06

4. Role of transportome in the pharmacogenomics of hepatocellular carcinoma and hepatobiliary cancer;Pharmacogenomics;2019-08

5. 6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming;Biomedicine & Pharmacotherapy;2019-03